As of Jan 10, 2025, Incyte Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at $72.0. This suggests it may be undervalued by 2.2% compared to its current price of around $70.5, using a WACC of 8.0% and growth rates of 3.0%.
As of Jan 10, 2025, Incyte Corporation's Weighted Average Cost of Capital (WACC) is approximately 8.0%.
As of Jan 10, 2025, Incyte Corporation's Enterprise Value (EV) is approximately $10.2B. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.